OncoHost is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about OncoHost. OncoHost develops personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand the patient's unique response to therapy and overcome one of the major obstacles in clinical oncology today – resistance to therapy. Based on robust scientific infrastructure and a strong IP position, OncoHost is launching an extensive clinical program with leading academic and clinical partners.
Company size
11-50 employees
Headquarters
Binyamina, Israel